| European Case Law Identifier: | ECLI:EP:BA:2015:T030111.20150203 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 03 February 2015 | ||||||||
| Case number: | T 0301/11 | ||||||||
| Application number: | 02735680.7 | ||||||||
| IPC class: | A61K 9/48 A61K 9/50 A61K 9/14 A61K 9/16 |
||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | D | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | METHOD OF ENCAPSULATING AN ACTIVE SUBSTANCE | ||||||||
| Applicant name: | CSIR | ||||||||
| Opponent name: | Critical Pharmaceuticals Limited | ||||||||
| Board: | 3.3.07 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Amendments - added subject-matter (yes) Requests filed with the statement of grounds - admitted (no) |
||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t110301eu1.html
Date retrieved: 17 May 2021
